We’re excited to announce another significant milestone — Applied Cells has officially submitted a Type II Master File (MAF) for the MARS® Bar system to the U.S. Food and Drug Administration (FDA), under the Center for Biologics Evaluation and Research
We’re excited to share BIG NEWS — Applied Cells is now officially ISO 13485:2016 certified for the design and manufacture of sterile human cell separation systems intended for human cell therapy. This certification is a major milestone for our team
CAR-T cell therapies have shown great success in treating hematological cancers, including leukemia, lymphoma and multiple myeloma, by using genetically modified T cells to effectively attack cancer. However, as these therapies continue to transform cancer treatment, barriers to access remain
As we step into 2025, we are happy to announce that our study results were published in Cytotherapy journal. Co-authored with researchers from the University of Chicago Medical Center and CellReady, the publication highlights MARS® Bar — a new, column-free
We are excited to announce the launch of its MARS® Ingenuity™ Reagent kits for fast and easy cell isolation. This innovative product line features both RUO and GMP-grade reagents, and has been specifically optimized for use on our MARS® Bar
Applied Cells had the pleasure of attending the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, CA, on December 9-12. The team had a wonderful time engaging in insightful discussions on the future of hematology
Products
Technology
Applications
Customer space
